There's no single best face moisturizer to source

I know that's an unsatisfying way to open a sourcing guide. But after five years of buying this category, I don't think there's a shortcut around it.

I handle procurement for a small skincare company—three in-house brands, sold mostly on Amazon plus a handful of wholesale accounts. Roughly $900K a year in contract-manufacturing spend, closer to $850K, I'd have to pull the actual number. That's across nine fillers and two packaging suppliers. My internal clients are the brand manager and the ops lead, and I answer to finance on every purchase order.

In that time I've spec'd dry-skin creams, a men's line, a sensitive-skin SKU, a natural-positioned line, and exactly one SPF product that nearly ended me.

It took me three years and about 40 private-label runs to understand that the spec sheet is rarely the deciding factor. The scenario is. Who's buying, under what regulatory path, on what timeline—those three things determine the formula more than any ingredient list.

So here's how I'd break it down. Four product scenarios, plus one dimension that cuts across all of them.

  • Scenario 1: Dry skin positioning
  • Scenario 2: Men's line
  • Scenario 3: Sensitive skin positioning
  • Scenario 4: SPF / daily protection
  • Cross-cutting: Deadline certainty

Scenario 1: Dry skin—the label matters less than the occlusive system

The common assumption is that dry skin needs more oil. So buyers spec a heavy, rich cream, the manufacturer delivers something that feels like lip balm, and it gets returned.

What I ask for now:

  • Glycerin percentage. It's the cheapest effective humectant in the industry and it works.
  • The occlusive system—petrolatum, dimethicone, squalane, shea, or a blend.
  • Whether they have corneometry or TEWL (transepidermal water loss) data on the finished formula.

Most contract manufacturers have this data sitting on a shelf from development. Ask for it. If they don't have it and can't get it, that tells you something about how they work.

Here's the counterintuitive part: our best-selling dry-skin SKU has the lowest oil content of the three versions we've tested. It just has a better occlusive blend and a texture people will actually apply twice a day. A rich cream that feels unpleasant gets used once and abandoned, and an abandoned moisturizer doesn't moisturize.

Scenario 2: Men's—check whether it's a formula or a fragrance swap

Plenty of suppliers do genuine formulation work for male skin, which tends to be oilier, thicker, and shaved more often. But there's a common shortcut: same base formula as the women's SKU, fragrance added, black carton, $4 more at retail.

That's not automatically wrong. It might be exactly the right call for your margin structure. But you should know which one you're paying for, so ask directly:

"Is this a distinct base formula, or is it a fragrance and packaging variant of an existing SKU?"

A supplier with nothing to hide answers that in one sentence.

What actually drives repurchase in this segment, at least according to our reviews and returns data:

  • Fast absorption and a matte finish
  • No white cast
  • Unscented, or very lightly scented
  • Packaging that doesn't look like it came off a beauty aisle shelf

Texture, not ingredients, is the differentiator here. If you're choosing between spending budget on a fancy extract blend or on getting the skin feel right, spend it on the skin feel.

Scenario 3: Sensitive skin—"natural" and "gentle" are not the same thing

This is where I see the most expensive mistakes, including one of mine.

Essential oils—lavender, citrus, eucalyptus—are natural. They're also among the most frequently cited causes of contact irritation in cosmetic products. "Natural" preservative systems often mean weaker preservation, which introduces microbial risk. Botanical extracts add dozens of potential sensitizers to an otherwise clean formula.

If you're sourcing for sensitive skin, the boring answer is the right answer: short ingredient list, fragrance-free, a proven preservative system, and actual test data. Phenoxyethanol with ethylhexylglycerin, or sodium benzoate with potassium sorbate, are the workhorses. Ask which one the formula uses.

Specifically, request:

  • HRIPT (Human Repeat Insult Patch Test) results, or an equivalent sensitization study
  • Preservative efficacy testing—ISO 11930 or USP <51> are the common standards
  • Confirmation that testing was done on the finished formula, including fragrance, not just the base

That last one matters more than people think. A lot of suppliers test the base and leave the fragrance out of the panel. That's fine right up until it isn't.

I got burned in 2023. We specified a natural positioning for a sensitive-skin SKU and the formula came back with a citrus-peel extract blend. Beautiful story on the marketing sheet. We launched. Within six weeks we had a cluster of complaints I'd rather not relitigate. Reformulated without the extracts, relaunched, sales recovered. Cost us roughly a quarter of momentum on that SKU, plus the rework fees.

Natural is a positioning decision. It is not a safety claim. Treat those as two separate conversations.

Scenario 4: SPF—your timeline changes before anything else does

Everything is different here. In the US, a moisturizer making an SPF claim is regulated as an over-the-counter drug, not a cosmetic. It needs a Drug Facts panel, and the SPF value has to be supported by testing conducted under the FDA's sunscreen monograph (21 CFR Part 352). That's not a marketing decision. It's a regulatory gate.

What that means in practice:

  • SPF testing adds real lead time. Budget four to eight weeks before the formula is even locked. If the test comes back low, you reformulate and start over.
  • Not every filler can make it. Sunscreen manufacturing requires FDA drug establishment registration, which sits in a different regulatory bucket than cosmetics. Under MoCRA (enacted December 2022), cosmetic facility registration and product listing requirements took effect, with FDA running enforcement discretion on those through July 1, 2024. Sunscreens were already in a separate, older framework. Verify your manufacturer's registration status directly—check FDA's own current documentation, since the guidance in this area has continued to move.
  • Stability testing typically runs 12 weeks at accelerated conditions (40°C / 75% RH). You can sometimes parallel-path it with SPF testing. Sometimes you can't, because a failed SPF test changes the formula and resets the clock.

One counterintuitive piece of advice: fight your formulator on the SPF number. Higher SPF usually means more UV filters, which means a heavier and tackier feel. The best-selling SPF moisturizers are the ones people actually wear every day. An SPF 30 that feels good outperforms an SPF 50 that lives in a drawer. Consumers don't apply enough product to hit the label number anyway.

If you're targeting a spring or summer launch, you're starting in the fall. Not January.

The dimension that cuts across all four: deadline certainty

In March 2025 we paid about 18% over the standard quote to move a fill run up three weeks. The alternative was missing a retail reset window worth roughly $40,000 in first-quarter revenue.

I didn't enjoy writing that check. But the premium wasn't buying speed. It was buying a date I could put in front of a retail buyer and defend.

The most frustrating part of this job is that "probably on time" is the most expensive phrase in sourcing. It costs nothing to say and everything to believe. I've been burned twice on it—once on packaging, once on a fill run that slipped eleven days with no warning.

Now we build a rush-fee line into the budget for anything tied to a dated launch. If we don't use it, it's a good quarter. If we do, we're not scrambling.

Dodged a bullet last fall, too. We were two clicks from approving an SPF order with a filler whose drug registration had lapsed. Caught it on a routine document check. That would've been a recall, not a delay. Worth the twenty minutes it took to look.

So which scenario are you actually in?

Three questions, and they're not complicated.

1. Who's buying, and what do they complain about? Pull your returns data and customer service tickets before you spec anything. If the top complaint on your current SKU is "feels greasy," you have a texture problem and no ingredient change will fix it. If it's "it stings," you have a formula problem. Read the tickets first.

2. Is your product a cosmetic or a drug? If there's an SPF claim, the answer in the US is drug. That single answer changes your manufacturer shortlist, your lead time, and your cost by a wide margin. No other scenario variable has that kind of leverage.

3. What's your deadline, and what does missing it cost? If the answer is "no hard deadline," optimize for cost and take the slower quote. If you're tied to a retail reset, a trade show, or a Q4 window, price the rush fee in from day one rather than discovering it in week nine.

If you're in more than one scenario—and most brands are—don't try to serve them all with one SKU. Pick the hero, put the rest in a secondary.

My first private-label run tried to be sensitive, natural, and for dry skin. It was mediocre at all three.

Actually, that's not quite right. We didn't discontinue it after the first year—we reformulated it twice and then discontinued it. Which is worse, and more expensive.

Pick your scenario. Then pick your formula.